Sly Saint
Senior Member (Voting Rights)
The UK Government has announced it will inject over £800m of funding to support specialist research facilities across the country to undertake experimental medicine research and advance the UK’s response to patient safety challenges.
The funding, which will be allocated by the National Institute for Health and Care Research (NIHR), includes £790m awarded to 20 NIHR biomedical research centres (BRCs) across England over the next five years to drive innovation in the diagnosis and treatment of various high-priority disease areas including cancer, dementia and mental health.
The remaining £25m has been awarded to six NIHR patient safety research centres (PSRCs) over the next five years to help improve understanding and resolution of patient safety challenges.
Health and social care secretary and deputy Prime Minister Thérèse Coffey said: "The pandemic has highlighted the importance of our booming research sector and the potential it has to not only strengthen health and care services, but lead to lifesaving developments.
"This additional funding will harness the UK’s world-leading innovation and allow research centres up and down the country to attract experts in their field and conduct research that saves lives.”
https://www.pmlive.com/pharma_news/...innovation_and_improve_patient_safety_1456936
eta: see also
https://www.nihr.ac.uk/news/new-mul...iscoveries-into-treatments-for-patients/31653
(includes list of NIHR Biomedical Research Centres 2022-2027 )
Last edited: